An outbreak of Japanese encephalitis in Southeast Asia: A meta-analysis
نویسندگان
doi
10.48309/jmpcr.2025.560593.1901چکیده
Japanese encephalitis (JE) remains a major vector-borne neurological disease across Asia and the Western Pacific, with substantial morbidity and mortality, despite the availability of effective vaccines. This meta-analysis synthesized seroprevalence data from Southeast Asia to provide an updated regional estimate and identify key demographic and environmental risk factors. Following PRISMA guidelines, eight eligible studies published between 2001 and 2024 were analyzed. The pooled seroprevalence of Japanese encephalitis virus (JEV) was 37.11%, with wide geographical variability across countries. Diagnostic methods included ELISA (IgM/IgG), neutralization assays, and hemagglutination inhibition tests. Risk factor assessment showed no significant differences between young and adult or adult vs. elderly populations. In contrast, gender- and location-based variations were observed: males showed a modestly higher risk in some models, and rural populations exhibited a 35% higher likelihood of seropositivity than urban communities. These findings highlight persistent JE transmission in high-risk areas and support the need for strengthened vaccination coverage, enhanced vector management, and improved diagnostic capacity, particularly in rural settings. Continued surveillance and targeted public health strategies are essential to reduce the burden of JE and to guide future vaccine implementation efforts in Southeast Asia .